BioSpace News Archive

Biocon Licenses Three Generic Formulation Products to China Medical System Holdings

Agreement Extends Biocon’s Footprint to Greater China, the World’s 2nd Largest Pharma Market

September 15, 2019
·
3 min read
BioCapital

Enhancing the way epilepsy is managed by engaging community pharmacists

The University of Washington’s School of Pharmacy announced on Thursday, Sept. 12, a collaboration with global biopharmaceutical company UCB to improve access to care for people living with epilepsy.

September 15, 2019
·
5 min read
Drug Development

Orion Biotechnology to Initiate Clinical Trials of Its Innovative Microbicide Gel for HIV Prevention

Orion Biotechnology Canada Ltd. announced that the Polish National Regulatory Agency and Local Ethics Committee have given approval for the OB-002H-101 Phase 1 safety and acceptability study of OB-002H gel to start screening and enrollment.

September 15, 2019
·
3 min read
BioMidwest

Pelican BioThermal to Deliver Cold Chain Insights and Unique Virtual Reality Experience at LogiPharma 2019

Learn about bundled services and see Pelican BioThermal’s Crēdo™ on Reserve reusable shipper program in action

September 15, 2019
·
4 min read
Drug Development

NOXXON Initiates Patient Recruitment for Phase 1/2 Clinical Trial Combining NOX-A12 & Radiotherapy For The Treatment Of Brain Cancer Patients

NOXXON Pharma N.V. announced the start of recruitment of newly diagnosed brain cancer patients in a Phase 1/2 clinical trial combining the CXCL12 inhibitor NOX-A12 with radiotherapy.

September 15, 2019
·
4 min read
Pharm Country

Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients

Oncoceutics, Inc. announced a scientific publication in the Journal of Neuro-Oncology describing a complete response and other forms of clinical benefit in pediatric and adult H3 K27M-mutant glioma patients treated with ONC201 on expanded access protocols.

September 15, 2019
·
2 min read
Biotech Beach

Two-Day Conference Provides Leadership, Career Development and Education for Women in Hematology and Oncology

The LEAD conference hosted by Bio Ascend will empower women in the fields of Oncology and Hematology to overcome barriers.

September 15, 2019
·
3 min read
Biotech Beach

Koa Accel Launches As New Type Of Medical Device Accelerator, Embedding Expert, Invested Teams To Drive Innovations Forward, Faster, To Reduce Investor Risk

In a move to develop medical devices faster, at a lower cost, and with a greater likelihood of a successful exit, Koa Accel announced its launch as a next generation medical device accelerator.

September 15, 2019
·
3 min read
Deals

SpringWorks Therapeutics Announces Pricing Of Initial Public Offering

SpringWorks Therapeutics, Inc. announced the pricing of its initial public offering of 9,000,000 shares of its common stock at a price to the public of $18.00 per share.

September 15, 2019
·
3 min read